Alector shares jump as Roche licenses Parkinson's therapy in $1.27 billion deal
Biotechnology dealmaking is continuing in neurodegenerative disease as Alector secures a licensing agreement for its experimental Parkinson's treatment with Roche. The pact includes $100 million ...